These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 38203435)

  • 1. Skin Anti-Inflammatory Potential with Reduced Side Effects of Novel Glucocorticoid Receptor Agonists.
    Flori E; Mosca S; Kovacs D; Briganti S; Ottaviani M; Mastrofrancesco A; Truglio M; Picardo M
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel in vitro test systems for the determination of glucocorticoid receptor ligand-induced skin atrophy.
    Schoepe S; Schäcke H; Bernd A; Zöller N; Asadullah K
    Skin Pharmacol Physiol; 2010; 23(3):139-51. PubMed ID: 20051715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of anti-inflammatory and atrophogenic effects of glucocorticoids on reconstructed human skin.
    Weindl G; Castello F; Schäfer-Korting M
    Altern Lab Anim; 2011 May; 39(2):173-87. PubMed ID: 21639680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid therapy-induced skin atrophy.
    Schoepe S; Schäcke H; May E; Asadullah K
    Exp Dermatol; 2006 Jun; 15(6):406-20. PubMed ID: 16689857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of the Glucocorticoid and Mineralocorticoid Receptors in Skin Pathophysiology.
    Sevilla LM; Pérez P
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective Activator of the Glucocorticoid Receptor Compound A Dissociates Therapeutic and Atrophogenic Effects of Glucocorticoid Receptor Signaling in Skin.
    Klopot A; Baida G; Bhalla P; Haegeman G; Budunova I
    J Cancer Prev; 2015 Dec; 20(4):250-9. PubMed ID: 26734587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SEGRAs: a novel class of anti-inflammatory compounds.
    Schäcke H; Hennekes H; Schottelius A; Jaroch S; Lehmann M; Schmees N; Rehwinkel H; Asadullah K
    Ernst Schering Res Found Workshop; 2002; (40):357-71. PubMed ID: 12355726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell type-specific regulatory effects of glucocorticoids on cutaneous TLR2 expression and signalling.
    Su Q; Pfalzgraff A; Weindl G
    J Steroid Biochem Mol Biol; 2017 Jul; 171():201-208. PubMed ID: 28377308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms involved in the side effects of glucocorticoids.
    Schäcke H; Döcke WD; Asadullah K
    Pharmacol Ther; 2002 Oct; 96(1):23-43. PubMed ID: 12441176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid receptors GRα and GRβ are expressed in inflammatory dermatoses.
    Kubin ME; Hägg PM; Kokkonen N; Väyrynen JP; Haapasaari KM; Moilanen J; Kallioinen M; Hurskainen T; Tasanen K
    Eur J Dermatol; 2016; 26(1):21-7. PubMed ID: 26711698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous inflammation and proliferation in vitro: differential effects and mode of action of topical glucocorticoids.
    Lange K; Kleuser B; Gysler A; Bader M; Maia C; Scheidereit C; Korting HC; Schäfer-Korting M
    Skin Pharmacol Appl Skin Physiol; 2000; 13(2):93-103. PubMed ID: 10754457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Mechanisms of Glucocorticoids.
    Vandewalle J; Luypaert A; De Bosscher K; Libert C
    Trends Endocrinol Metab; 2018 Jan; 29(1):42-54. PubMed ID: 29162310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index.
    Schäcke H; Berger M; Rehwinkel H; Asadullah K
    Mol Cell Endocrinol; 2007 Sep; 275(1-2):109-17. PubMed ID: 17630119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoids and Glucocorticoid-Induced-Leucine-Zipper (GILZ) in Psoriasis.
    Sevilla LM; Pérez P
    Front Immunol; 2019; 10():2220. PubMed ID: 31572404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginsenoside Rg1, a novel glucocorticoid receptor agonist of plant origin, maintains glucocorticoid efficacy with reduced side effects.
    Du J; Cheng B; Zhu X; Ling C
    J Immunol; 2011 Jul; 187(2):942-50. PubMed ID: 21666059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mineralocorticoid receptor modulates timing and location of genomic binding by glucocorticoid receptor in response to synthetic glucocorticoids in keratinocytes.
    Carceller-Zazo E; Sevilla LM; Pons-Alonso O; Chiner-Oms Á; Amazit L; An Vu T; Vitellius G; Viengchareun S; Comas I; Jaszczyszyn Y; Abella M; Alegre-Martí A; Estébanez-Perpiñá E; Lombès M; Pérez P
    FASEB J; 2023 Jan; 37(1):e22709. PubMed ID: 36527388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects.
    Schäcke H; Schottelius A; Döcke WD; Strehlke P; Jaroch S; Schmees N; Rehwinkel H; Hennekes H; Asadullah K
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):227-32. PubMed ID: 14694204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long winding road to the safer glucocorticoid receptor (GR) targeting therapies.
    Lesovaya EA; Chudakova D; Baida G; Zhidkova EM; Kirsanov KI; Yakubovskaya MG; Budunova IV
    Oncotarget; 2022; 13():408-424. PubMed ID: 35198100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases.
    Schäcke H; Zollner TM; Döcke WD; Rehwinkel H; Jaroch S; Skuballa W; Neuhaus R; May E; Zügel U; Asadullah K
    Br J Pharmacol; 2009 Oct; 158(4):1088-103. PubMed ID: 19422381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PI3K inhibitors protect against glucocorticoid-induced skin atrophy.
    Agarwal S; Mirzoeva S; Readhead B; Dudley JT; Budunova I
    EBioMedicine; 2019 Mar; 41():526-537. PubMed ID: 30737086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.